Dermapharm Holding SE
DMPHFOTCHealthcare● Active
$59.00
+$19.44(+49.14%)
Market Cap$2.9B
P/E Ratio—
52W High$59
52W Low$39.56
Dermapharm Holding SE（DMPHF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · DMPHF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.13B | $0.17B | $0.06B | $0.22B | $0.29B |
| Depreciation & Amort. | $0.09B | $0.09B | $0.10B | $0.09B | $0.06B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | ($0.02B) | $0.01B | ($0.00B) | ($0.05B) |
| Net Cash from Operations | $0.18B | $0.20B | $0.22B | $0.29B | $0.25B |
| Investing Activities | |||||
| Capital Expenditure | ($0.04B) | ($0.04B) | ($0.04B) | ($0.04B) | ($0.06B) |
| Purchases of Investments | ($0.01B) | ($0.00B) | $0.00B | ($0.01B) | ($0.05B) |
| Sales of Investments | $0.00B | $0.00B | $0.01B | $0.01B | $0.06B |
| Net Cash from Investing | ($0.11B) | ($0.03B) | ($0.42B) | ($0.10B) | ($0.13B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.05B) | ($0.05B) | ($0.06B) | ($0.12B) | ($0.05B) |
| Debt Issued / Repaid | $0.07B | ($0.10B) | $0.30B | ($0.07B) | ($0.03B) |
| Net Cash from Financing | $0.01B | ($0.21B) | $0.20B | ($0.20B) | ($0.08B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.14B | $0.16B | $0.18B | $0.25B | $0.19B |
| FCF Margin %(computed) | 11.97% | 13.82% | 15.46% | 24.35% | 20.06% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · B
深入了解Dermapharm Holding SE
关于Dermapharm Holding SE（DMPHF）现金流量表
Dermapharm Holding SE 2025财年经营活动现金流$0.18B，自由现金流$0.14B（FCF利润率11.97%），资本支出($0.04B)。
常见问题
DMPHF · 4 问Dermapharm Holding SE 2025财年自由现金流$0.14B，同比down14.6%。
DMPHF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10